Evaluation of PCV15 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

Conditions: Pneumococcal Vaccines; Immunosuppression Interventions: Drug: 15-valent pneumococcal conjugate vaccine; Drug: 23-valent pneumococcal polysaccharide vaccine Sponsors: VA Sierra Nevada Health Care System; Merck Sharp& Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials